El pequeño tesoro de la Bolsa que gana más del 925% en la última década
Una compañía del Índice General se luce en el parqué en los últimos diez años. Destaca por gustar a todas las entidades que cubren su cotización, que creen que seguirá al alza a medio plazo. Leer
A Spanish company, Clínica Baviera, has seen an astounding 925% increase in value over the past decade, making it a standout performer among the 111 Spanish companies that make up the General Index. This small-cap firm has more than doubled its share price from €5.44 to the current €55.8, representing a staggering 925% appreciation.
Its performance this year has been equally impressive, with a gain of more than 12% since the start of January. Despite recent market volatility driven by changes in the European Central Bank’s policies, inflation concerns, and fluctuations in oil prices, analysts remain optimistic about Clínica Baviera's long-term prospects. The company, which specializes in ophthalmology, has benefited from the strategic investment of a Chinese group, Aier Eye, which controls 73.23% of its shares.
With a market capitalization of €910 million, Clínica Baviera has received a price target of €62.90 per share, indicating potential upside of 13.5% over the medium term.
Written by urgent.news from Expansion ES's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
